Luigi Francesco Iannone
Overview
Explore the profile of Luigi Francesco Iannone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Romozzi M, Munafo A, Burgalassi A, De Cesaris F, Vigani G, Altamura C, et al.
Headache
. 2025 Jan;
65(2):342-352.
PMID: 39825578
Antibodies targeting either the calcitonin gene-related peptide (CGRP), such as galcanezumab, fremanezumab, and eptinezumab, or the receptor (erenumab) have been approved for the prevention of episodic and chronic migraine. Although...
2.
Nociti V, Romozzi M, Annovazzi P, Fantozzi R, Tortorella C, Vercellino M, et al.
J Neurol Sci
. 2025 Jan;
469():123392.
PMID: 39808882
Background: Migraine affects up to 40% of people with multiple sclerosis (PwMS). This study aimed to evaluate the effectiveness and safety of the combination of antibodies (mAbs) against CGRP (anti-CGRP...
3.
Iannone L, Vaghi G, Sebastianelli G, Casillo F, Russo A, Silvestro M, et al.
J Headache Pain
. 2025 Jan;
26(1):4.
PMID: 39762740
Background: Rimegepant, a novel oral calcitonin gene-related peptide receptor antagonist, has been recently approved for the acute migraine treatment. While its efficacy was confirmed in randomized clinical trials, no data...
4.
Romozzi M, Spartano S, LErario F, Iannone L, Trigila V, Gentile A, et al.
Brain Commun
. 2024 Dec;
7(1):fcae447.
PMID: 39723107
Familial hemiplegic migraine type 2 results from pathogenic variants in the gene, which encodes for a catalytic subunit of sodium/potassium ATPase. This extremely rare autosomal dominant disorder manifests with a...
5.
Romozzi M, Lokhandwala A, Vollono C, Vigani G, Burgalassi A, Garcia-Azorin D, et al.
Cephalalgia
. 2024 Dec;
44(12):3331024241262751.
PMID: 39654467
Background: The present study aimed to determine whether machine-learning (ML)-based models can predict 3-, 6, and 12-month responses to the monoclonal antibodies (mAbs) against the calcitonin gene-related peptide (CGRP) or...
6.
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study
Dalla Volta G, Russo A, Silvestro M, Ornello R, Caponnetto V, Sacco S, et al.
Cephalalgia
. 2024 Nov;
44(11):3331024241299453.
PMID: 39587967
Background: Migraine with aura (MwA) is a debilitating disorder characterized by paroxysmal attacks of pain preceded or accompanied by reversible neurological symptoms. While the pathophysiology remains unclear, trigeminovascular system activation...
7.
Romozzi M, Trigila V, Cuffaro G, Marcelli S, Iannone L, Calabresi P, et al.
Eur J Neurol
. 2024 Nov;
32(1):e16568.
PMID: 39587646
Objective: This study aimed to analyze the microcirculation of the macula, the optic nerve, and the choroid in patients with migraine by optical coherence tomography angiography (OCTA) during spontaneous migraine...
8.
Titiz M, Landini L, Souza Monteiro de Araujo D, Marini M, Seravalli V, Chieca M, et al.
Nat Commun
. 2024 Nov;
15(1):10142.
PMID: 39587068
Over 60% of women with endometriosis experience abdominopelvic pain and broader pain manifestations, including chronic back pain, fibromyalgia, chronic fatigue, vulvodynia, and migraine. Although the imbalance of proinflammatory mediators, including...
9.
Burgalassi A, Romozzi M, Vigani G, De Icco R, Raffaelli B, Boccalini A, et al.
Cephalalgia
. 2024 Nov;
44(11):3331024241273968.
PMID: 39497430
Background: The anti-calcitonin gene-related peptide (CGRP), or its receptor (CGRP/R) monoclonal antibodies (mAbs), offer targeted, effective, and tolerated drugs for migraine. However, about 25% of patients fail to achieve a...
10.
Romozzi M, Trigila V, Tosto F, Cuffaro G, Garcia-Azorin D, Iannone L, et al.
Eur J Neurol
. 2024 Sep;
31(12):e16472.
PMID: 39318133
Background: Visual snow (VS) and visual snow syndrome (VSS) are becoming increasingly recognized. However, their prevalence worldwide is unknown. This study aimed to investigate lifetime prevalence and describe the clinical...